ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.250
-0.100 (-2.99%)
At close: Jul 15, 2025, 4:00 PM
3.170
-0.080 (-2.46%)
After-hours: Jul 15, 2025, 4:27 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $364.68 million as of July 15, 2025. Its market cap has increased by 40.89% in one year.
Market Cap
364.68M
Enterprise Value
616.50M
1-Year Change
40.89%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $364.68M, a decrease of -82.15%. That is a compound annual growth rate of -28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 375.90M | 95.36% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |